Lupin gets EDQM nod for its Mandideep facility
30 July 2018 | News
Over the past few months, Lupin has continued to drive multiple initiatives to further strengthen manufacturing standards and best practices to be amongst the best, he added.
Image Credit: Wikipedia
Drug firm Lupin has said that it has received attestation from European Directorate for the Quality of Medicines (EDQM) for its Mandideep facility in Madhya Pradesh. The unit was inspected by EDQM in March this year.
"The inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for Quality Management Systems based on cGMP as laid under European Union rules governing medicinal products," according to the company.
Lupin MD Nilesh Gupta said: "We are happy to receive the EDQM attestation for our Mandideep facility."
Over the past few months, Lupin has continued to drive multiple initiatives to further strengthen manufacturing standards and best practices to be amongst the best, he added.
